PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CAMPBELL, Calif.--(BUSINESS WIRE)-- #AI--Veteran finance executive Scott Rogers appointed Saama CFO following recent $430 million dollar growth investment announcement

Saama Appoints Scott Rogers as Company's Chief Financial Officer

Thermo Fisher Scientific

WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD was named one of the “Best Workplaces in Greater China™ 2021” by Great Place to Work® for successfully creating an inclusive workplace experience.

PPD Named to ‘Best Workplaces in Greater China' for Second Consecutive Year

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD named “Best Vaccine CRO of the Year” at the APAC Vaccine Excellence Awards 2021 for its strong presence, extensive experience and quality delivery

PPD Named ‘Best Vaccine CRO of the Year' in Asia-Pacific

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD earned numerous honors at the 2021 PharmaTimes Clinical Researcher of the Year-The Americas competition.

PPD Wins Multiple Awards at Clinical Researcher of the Year Competition

PPD, Inc. (PPD) CEO David Simmons on Q3 2021 Results - Earnings Call Transcript

PPD, Inc. (PPD) delivered earnings and revenue surprises of 16.22% and 7.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

PPD, Inc. (PPD) Tops Q3 Earnings and Revenue Estimates

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Reports Third Quarter and Year-To-Date 2021 Results

PPD Reports Third Quarter and Year-To-Date 2021 Results

PALO ALTO, Calif.--(BUSINESS WIRE)-- #biotech--Medable secured $304 million in Series D funding at $2.1 billion valuation to accelerate global adoption of digital and decentralized clinical trials.

Medable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger Global

PPD, Inc. (PPD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for PPD, Inc. (PPD)

PPD, Inc. (PPD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PPD, Inc. (PPD) Earnings Expected to Grow: Should You Buy?

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD was named “Clinical Research Company of the Year” at the 2021 PharmaTimes Clinical Researcher of the Year International competition in London.

PPD Named Clinical Research Company of the Year for Second Consecutive Year

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Announces Third Quarter 2021 Earnings Conference Call

PPD Announces Third Quarter 2021 Earnings Conference Call

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD is the recipient of the 2021 Eagle Award for its commitment to advancing clinical research professionalism through strong site partnerships.

Society for Clinical Research Sites Names PPD Winner of Prestigious Eagle Award

Aethlon Medical

SAN DIEGO, Sept. 30,  2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it has entered into an agreement with PPD, Inc. (Nasdaq: PPD), a leading global contract research organization (CRO), for PPD to oversee the company's clinical studies investigating the Hemopurifier, Aethlon's therapeutic blood filtration system, for infectious disease indications.

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

WILMINGTON, N.C.--(BUSINESS WIRE)--For the second consecutive year, PPD received two Brandon Hall Group Human Capital Management “Excellence in Learning” Awards.

PPD Earns Gold Award for Excellence in Employee Learning and Development

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD is a recipient of the 2021 ATD BEST Awards, which recognize enterprise-wide success as a result of employee talent development.

PPD Receives Award Recognizing Employee Talent Development

Stryker

UnitedHealth Group

Zai Lab Ltd.

The Vanguard Health Care Fund (Trades, Portfolio) has revealed its portfolio for the second quarter of this year. Major trades for the fund include a reduction in its portfolio-leading UnitedHealth Group Inc. ( UNH , Financial) position, selling out of its PPD Inc. ( PPD , Financial) and Smith & Nephew PLC ( LSE:SN.

The Vanguard Health Care Fund's Top 5 Trades of the 2nd Quarter

PPD, Inc. (PPD) CEO David Simmons on Q2 2021 Results - Earnings Call Transcript

PPD, Inc. (PPD) delivered earnings and revenue surprises of 14.71% and 17.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

PPD, Inc. (PPD) Surpasses Q2 Earnings and Revenue Estimates

Shares of PPD (NASDAQ:PPD) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 56.00% year over year to $0.39, which beat the estimate of $0.33.

Recap: PPD Q2 Earnings

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Reports Second Quarter and Year-To-Date 2021 Results

PPD Reports Second Quarter and Year-To-Date 2021 Results

PPD, Inc. (PPD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PPD, Inc. (PPD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD has been named one of the Best Workplaces in Asia by Great Place to Work®, a global authority on high-trust, high-performance workplace cultures.

PPD Recognized as a Best Place to Work in Asia

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD to Host Second Quarter 2021 Earnings Conference Call

News for PPD Stock (PPD)